Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Ondansetron Versus Metaclopromide Treatment in Infants With Gastro Oesophageal Reflux, a Comparative Study of Short Trial.

NCT06898268 is registered in ClinicalTrials.gov with Muhammad Aamir Latif as lead sponsor.

NCT NCT06898268
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06898268 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Ondansetron Versus Metaclopromide Treatment in Infants With Gastro Oesophageal Reflux, a Comparative Study of Short Trial.
Lead sponsor
Muhammad Aamir Latif
Phase
Not applicable
Overall status
Completed
Start date
July 1, 2024
Completion date
December 31, 2024
Enrollment
290 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastroesophageal reflux disorder